Alaunos Therapeutics, Inc. (TCRT) Reports In-Line Q1 EPS

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• KeyBanc Upgrades Acadia Realty Trust (AKR) to Overweight
• INVO Fertility (IVF) Tops Q2 EPS by 105c